Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03363776
Title An Immuno-Therapy Study of Experimental Medication BMS-986277 Given Alone and in Combination With Nivolumab in Epithelial Cancers
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

prostate cancer

breast cancer

colorectal cancer

ovarian cancer

transitional cell carcinoma

pancreatic cancer

Therapies

BMS-986277

BMS-986277 + Nivolumab

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.